Modeling the Interaction between the Microenvironment and Tumor Cells in Brain Tumors
Related Experiment Video
Updated: Dec 5, 2025

Quantifying the Brain Metastatic Tumor Micro-Environment using an Organ-On-A Chip 3D Model, Machine Learning, and Confocal Tomography
Published on: August 16, 2020
Claudia Pasqualini1, Tatsuya Kozaki2, Marco Bruschi3
1Children and Adolescent Oncology Department, Gustave Roussy, Paris-Saclay University, Villejuif, France.
Abstract:
Despite considerable recent advances in understanding and treating many other cancers, malignant brain tumors remain associated with low survival or severe long-term sequelae. Limited progress, including development of immunotherapies, relates in part to difficulties in accurately reproducing brain microenvironment with current preclinical models. The cellular interactions among resident microglia, recruited tumor-associated macrophages, stromal cells, glial cells, neurons, and cancer cells and how they affect tumor growth or behavior are emerging, yet many questions remain. The role of the blood-brain barrier, extracellular matrix components, and heterogeneity among tumor types and within different regions of a single tumor further complicate the matter. Here, we focus on brain microenvironment features impacted by tumor biology. We also discuss limits of current preclinical models and how complementary models, such as humanized animals and organoids, will allow deeper mechanistic insights on cancer biology, allowing for more efficient testing of therapeutic strategies, including immunotherapy, for brain cancers.
Insights
Malignant brain tumors have poor outcomes due to challenges in modeling the brain microenvironment. New models like humanized animals and organoids offer better insights for developing brain cancer therapies, including immunotherapies.
Area of Science:
- Neuro-oncology
- Cancer Biology
- Immunotherapy
Background:
- Malignant brain tumors have poor prognoses despite advances in other cancer treatments.
- Current preclinical models struggle to accurately replicate the complex brain microenvironment, hindering therapeutic development, especially for immunotherapies.
Purpose of the Study:
- To examine brain microenvironment features influenced by tumor biology.
- To discuss limitations of existing preclinical models for brain cancers.
- To highlight the potential of complementary models for advancing therapeutic strategies.
Main Methods:
- Focus on brain microenvironment characteristics affected by tumor biology.
- Analysis of cellular interactions within the brain tumor microenvironment.
- Review of current preclinical models and their limitations.
Main Results:
- The brain microenvironment, including cellular interactions, extracellular matrix, and the blood-brain barrier, presents significant challenges.
- Existing preclinical models inadequately represent the complexity of brain tumors.
- Heterogeneity within tumors and across tumor types complicates research.
Conclusions:
- Advanced models like humanized animals and organoids are crucial for deeper mechanistic insights into brain cancer biology.
- These complementary models can facilitate more effective testing of therapeutic strategies, including immunotherapies.
- Improving preclinical models is essential for overcoming the challenges in treating malignant brain tumors.

